{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:53:09Z","timestamp":1788472389818,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005993","name":"National Council for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005993","name":"National Council for Scientific Research","doi-asserted-by":"publisher","award":["2015-2016\/41"],"award-info":[{"award-number":["2015-2016\/41"]}],"id":[{"id":"10.13039\/501100005993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["14895"],"award-info":[{"award-number":["14895"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.taap.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T18:00:34Z","timestamp":1504980034000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["CYP4A\/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats"],"prefix":"10.1016","volume":"334","author":[{"given":"Safaa H.","family":"Hammoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal G.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaad A.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-7070","authenticated-orcid":false,"given":"Mahmoud M.","family":"El-Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.09.007_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/FJC.0b013e3181e74d83","article-title":"Role of PPAR\/nitric oxide synthase signaling in the cyclosporine-induced attenuation of endothelium dependent renovascular vasodilation","volume":"56","author":"Abd-Elrahman","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0010","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1161\/01.CIR.94.12.3341","article-title":"Nitric oxide attenuates the release of endothelium \u00ad derived hyperpolarizing factor","volume":"94","author":"Bauersachs","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2017.09.007_bb0015","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.hjh.0000242412.88653.f2","article-title":"Nitric oxide\/cytochrome P450 interactions in cyclosporin A-induced effects in the rat","volume":"24","author":"Blanton","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.taap.2017.09.007_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI115293","article-title":"Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells","volume":"88","author":"Bunchman","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2017.09.007_bb0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0165-6147(02)02050-3","article-title":"EDHF: bringing the concepts together","volume":"23","author":"Busse","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.taap.2017.09.007_bb0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1476-5381.1989.tb12619.x","article-title":"Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit","volume":"98","author":"Cairns","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0035","first-page":"567","article-title":"Regulation of preglomerular microvascular 20-hydroxyeicosatetraenoic acid levels by salt depletion","volume":"7","author":"Carroll","year":"2001","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.taap.2017.09.007_bb0040","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2017.09.007_bb0045","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1128\/MCB.00217-13","article-title":"Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression","volume":"33","author":"Eid","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2017.09.007_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0070029","article-title":"20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway","volume":"8","author":"Eid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.09.007_bb0055","first-page":"1","article-title":"mTORC2 signaling regulates Nox4-induced podocyte depletion in diabetes","author":"Eid","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2017.09.007_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00210-014-1074-1","article-title":"Central modulation of cyclosporine-induced hypertension","volume":"388","author":"El-Gowelli","year":"2015","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0065","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1440-1681.2008.04983.x","article-title":"Exacerbation by nicotine of the cyclosporine A- induced impairment of \u03b2 -adrenoceptor- mediated renal vasodilation in rats","volume":"35","author":"El-Gowilly","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.taap.2017.09.007_bb0070","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1139\/y03-106","article-title":"Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone","volume":"81","author":"Ellis","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1152\/ajpregu.00606.2011","article-title":"Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease","volume":"302","author":"Elmarakby","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.taap.2017.09.007_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)01720-5","article-title":"Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations","volume":"468","author":"El-Mas","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2004.01.025","article-title":"Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and \u03b2-adrenergic renal vasodilations","volume":"487","author":"El-Mas","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00005344-200404000-00012","article-title":"Regional and endothelial differences in cyclosporine attenuation of adenosine receptor-mediated vasorelaxations","volume":"43","author":"EL-Mas","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0095","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1139\/y05-116","article-title":"The a1 - adrenergic receptor not the DA 1 - dopaminergic receptor mediates cyclosporine \u2013 SKF38393 renovascular interaction","volume":"1136","author":"El-Mas","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejphar.2008.04.048","article-title":"Pharmacological characterization of cellular mechanisms of the renal vasodilatory effect of nicotine in rats","volume":"588","author":"El-Mas","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bcp.2010.11.013","article-title":"Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function","volume":"81","author":"El-Mas","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.112.191940","article-title":"Estrogen provokes the depressant effect of chronic nicotine on vagally mediated reflex chronotropism in female rats","volume":"342","author":"El-Mas","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2017.09.007_bb0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2012.08.021","article-title":"Redox imbalances incite the hypertensive, baroreflex, and autonomic effects of cyclosporine in rats","volume":"694","author":"El-Mas","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2015.01.018","article-title":"Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling","volume":"284","author":"El-Mas","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2133.1997.tb08751.x","article-title":"Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis","volume":"136","author":"Erkko","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.taap.2017.09.007_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.36.2.270","article-title":"Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor \u2013 mediated responses in coronary arteries","volume":"36","author":"Fisslthaler","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/hh2101.099268","article-title":"Cytochrome p450 and vascular homeostasis","volume":"89","author":"Fleming","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2017.09.007_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prostaglandins.2014.12.001","article-title":"Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETs","volume":"0","author":"Garcia","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.taap.2017.09.007_bb0145","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0022-3565(25)22774-4","article-title":"Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators","volume":"250","author":"Gerkens","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2017.09.007_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000054216","article-title":"Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?","volume":"24","author":"Gossmann","year":"2001","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.taap.2017.09.007_bb0155","first-page":"199","article-title":"Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison","volume":"70","author":"Higgins","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.taap.2017.09.007_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"7","key":"10.1016\/j.taap.2017.09.007_bb0165","first-page":"560","article-title":"Genetic targeting of arginase-II in mouse prevents renal oxidative stress and inflammation in diet-induced obesity","volume":"7","author":"Huang","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.taap.2017.09.007_bb0170","doi-asserted-by":"crossref","first-page":"H952","DOI":"10.1152\/ajpheart.1994.266.3.H952","article-title":"Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed","volume":"266","author":"Hwa","year":"1994","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2017.09.007_bb0175","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1152\/ajprenal.2000.279.6.F965","article-title":"Eicosanoid regulation of the renal vasculature","volume":"279","author":"Imig","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2017.09.007_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2017.09.007_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5487\/TR.2014.30.3.141","article-title":"Endothelium-derived relaxing factors of small resistance arteries in hypertension","volume":"30","author":"Kang","year":"2014","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.taap.2017.09.007_bb0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s002280050706","article-title":"Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions","volume":"55","author":"Katoh","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0195","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/jcbfm.2012.68","article-title":"Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitor","volume":"32","author":"Kawasaki","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.taap.2017.09.007_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.80.1.1","article-title":"Mechanisms of coronary microvascular dilation induced by the activation of pertussis toxin-sensitive G proteins are vessel-size dependent. Heterogeneous involvement of nitric oxide pathway and ATP-sensitive K+ channels","volume":"80","author":"Komaru","year":"1997","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.taap.2017.09.007_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/14728214.8.1.47","article-title":"Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases immunosuppressants in advanced clinical development for organ","volume":"8","author":"Kovarik","year":"2003","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.taap.2017.09.007_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00041552-200101000-00013","article-title":"Cytochrome P450 metabolites of arachidonic acid in the control of renal function","volume":"10","author":"Maier","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.taap.2017.09.007_bb1210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1993.61","article-title":"Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants","volume":"43","author":"Mourad","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2017.09.007_bb0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bjp.0704101","article-title":"HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme","volume":"133","author":"Miyata","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.taap.2017.09.007_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.01.034","article-title":"Blockade of endothelin ETA, but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions","volume":"727","author":"Nasser","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0230","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.HYP.0000085195.38870.44","article-title":"Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension","volume":"42","author":"Nishiyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0235","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semnephrol.2007.03.010","article-title":"Renal disease in recipients of nonrenal solid organ transplantation","volume":"27","author":"Ojo","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.taap.2017.09.007_bb0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.HYP.32.5.849","article-title":"Role of nitric oxide in cyclosporine A-induced hypertension","volume":"32","author":"Oriji","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-385061-4.00002-7","article-title":"Vascular pharmacology of epoxyeicosatrienoic acids","volume":"60","author":"Pfister","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0250","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1124\/dmd.32.7.727","article-title":"The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney","volume":"32","author":"Poloyac","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2017.09.007_bb0255","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":"Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial","volume":"354","author":"Rahn","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2017.09.007_bb0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cardiores.2004.10.029","article-title":"The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation","volume":"65","author":"Randriamboavonjy","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2017.09.007_bb0265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2008.600","article-title":"Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury","volume":"75","author":"Regner","year":"2009","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.taap.2017.09.007_bb0270","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-3565(25)12732-8","article-title":"Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed: role of extracellular calcium","volume":"254","author":"Rego","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2017.09.007_bb0275","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2017.09.007_bb0280","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.HYP.36.4.642","article-title":"Nifedipine prevents changes in nitric oxide synthase mRNA levels induced by cyclosporine","volume":"36","author":"S\u00e1nchez-Lozada","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0285","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1254\/jphs.FP0040574","article-title":"Increased excretion of urinary 20-HETE in rats with cyclosporine-induced nephrotoxicity","volume":"97","author":"Seki","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2017.09.007_bb0290","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1476-5381.2012.02062.x","article-title":"K Ca3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS","volume":"167","author":"Simonet","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0295","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00005344-199512000-00003","article-title":"Endothelium dependent relaxation in the isolated rat kidney impairment by cyclosporine.pdf","volume":"26","author":"Stephan","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0300","first-page":"141","article-title":"Cardiovascular effects of cyclosporin treatment in an experimental model","volume":"21","author":"Tavares","year":"2002","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.taap.2017.09.007_bb0305","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1524-6175.2007.06588.x","article-title":"Hypertension after renal transplant","volume":"9","author":"Tedla","year":"2007","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.taap.2017.09.007_bb1305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.25.1.77","article-title":"Hypertension after renal transplantation. Calcium channel or converting enzyme blockade?","volume":"25","author":"van der Schaaf","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2016.01.006","article-title":"Decreased bioavailability of nitric oxide in aorta from ovariectomized senescent mice: role of cyclooxygenase","volume":"76","author":"Vidal-G\u00f3mez","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.taap.2017.09.007_bb0315","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.HYP.0000090123.55365.BA","article-title":"Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension","volume":"42","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0320","series-title":"20-HETE and Renal Pressure Natriuresis Elevations in Renal Interstitial Hydrostatic Pressure and 20-Hydroxyeicosatetraenoic Acid Contribute to Pressure Natriuresis","first-page":"687","volume":"2","author":"Williams","year":"2007"},{"key":"10.1016\/j.taap.2017.09.007_bb0325","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-hete: a new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.intimp.2016.02.009","article-title":"Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-\u03baB pathways","volume":"33","author":"Xu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2017.09.007_bb0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.0000150782.28485.91","article-title":"Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats","volume":"45","author":"Zhang","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2017.09.007_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2015.03.004","article-title":"Cyclosporin a upregulates ETB receptor in vascular smooth muscle via activation of mitogen-activating protein kinases and NF- \u03baB pathways","volume":"235","author":"Zheng","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2017.09.007_bb0345","first-page":"15","article-title":"The effect of calcium channel blockers on cyclosporine A (Cs A) induced nephrotoxicity in rats","volume":"96","author":"Zima","year":"1995","journal-title":"Sborn\u00edk l\u00e9kar\u0306sk\u00fd"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T17:17:18Z","timestamp":1750871838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17303794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":71,"alternative-id":["S0041008X17303794"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.09.007","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP4A\/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}